Guidelines on the management of ascites in cirrhosis
Guruprasad P. Aithal(NIHR Nottingham Digestive Diseases Biomedical Research Unit), Sumita Verma(Brighton and Sussex Medical School)
Cited by 661
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
|Hepatology|2017|657
Autoimmune hepatitis
|The Lancet|2013|279